Proteome Sciences Share Discussion Threads

[monte1] 11/3/2021 15:07

Indeed.

I note that there is a link to a 16 year old post in the header. I shall strongly lobby the thread owner to clean things up on an ASAP basis.

[tom barnaby] 11/3/2021 15:03

I dont recall if we have been over this before, but some further analysis of the links may be required.

[tom barnaby] 11/3/2021 15:03

Well indeed.

Looking at the state of some of those links in the header, the avatar could do with an assistant, imo. Urgently too.

[monte1] 11/3/2021 14:48

I presume it is just a case of the paperwork lagging behind the actual update Tom. I mean, what avatar actually enjoys doing the admin eh?

[tom barnaby] 11/3/2021 14:46

Tom Barnaby MUST be removed too, of course.

The avatar has been posting on a thread created by Tom Barnaby. If Tom Barnaby was filtered he would not be able to see that thread, let alone post on it.

[monte1] 11/3/2021 14:44

I am not going to lie - I am eagerly looking forward to issue of goatherds updated ‘filter list’ with my avatar removed - that will be worth the cost of my investment here alone.

[monte1] 11/3/2021 14:41

Noted Tom - any icebergs on the horizon?

[tom barnaby] 11/3/2021 14:40

Those shrewd strong US buyers are keeping their powder dry, I note. Waiting for the weak holders to lose their nerve, imIo.

[monte1] 11/3/2021 14:14

#58556

An avatar has more chance at the moment of walking unchallenged into Fort Knox wearing a stripey top, black eye mask and carrying a cloth bag marked ‘swag’ than making it past the first 12 lines of defence and gaining access to the inner sanctum of a Doctors Surgery.

[tom barnaby] 11/3/2021 14:03

From the claims this was reaching an all time low earlier this week, the thread has shown there is life in the old dog stock yet.

More value today than a month of the Richards nonsense.

[monte1] 11/3/2021 13:58

#58557

I may be certifiably insane but I am not that daft. Besides, the nurses ‘here’ have now removed my wallet - and my belt, shoelaces & all dignity for that matter.

[monte1] 11/3/2021 13:57

I understand that the avatar DominicCummings tried to purchase a Joy Milne (21) online but the transaction was blocked as it was believed it was to be used for unauthorised purposes.

[bluemango] 11/3/2021 13:54

Monte, now that you've presumably had lunch (and a glass or two of fine claret) how about throwing another couple of grand at this? Otherwise those pesky MMs will think they have the upper hand and keep the lid on this for longer.

[bluemango] 11/3/2021 13:50

#58553 The solution, surely, is for Mrs Joy Milne (68) to be cloned, ready to spring out of the cupboard at your local GP surgery anywhere in the UK, as and when required.

What part of that you patent, I'm not sure - but PRM will have it covered whatever.

[tom barnaby] 11/3/2021 13:47

Has PRM got a patent on any of the models Joy Milne (1-67) or any of the later versions?

[tom barnaby] 11/3/2021 13:43

58552

Sorry 1xtrader.

[1xtrader] 11/3/2021 13:41

Tom that is not an answer that is research task for you

[tom barnaby] 11/3/2021 13:39

This is the contents of the useful link in the header 1xtrader.

maxwellsdemon2 Feb '06 - 08:51 - 26628 of 61525 0 0 0

Here is an upgraded (from yesterday's post) list of search results for patents that PRM either own directly or have some interest in. The list is probably not complete and contains many duplicates.

Hanash

1. (WO 01/11372) ANNEXINS AND AUTOANTIBODIES USED AS MARKERS FOR CANCER
[Repub: 11.04.2002]
2. (WO 01/11372) ANNEXINS AND AUTOANTIBODIES USED AS MARKERS FOR CANCER
3. (WO 00/26668) S100 PROTEINS AND AUTOANTIBODIES AS SERUM MARKERS FOR CANCER
[Repub: 08.09.2000]
4. (WO 00/26668) S100 PROTEINS AND AUTOANTIBODIES AS SERUM MARKERS FOR CANCER
5. (WO 99/00671) METHOD FOR IDENTIFICATION OF TUMOR ANTIGENS WITH AUTOANTIBODIES IN SERUM
[Repub: 10.06.1999]
6. (WO 99/00671) METHOD FOR IDENTIFICATION OF CELLULAR PROTEIN ANTIGENS AND PRESENCE OF ANTIBODIES TO SPECIFIC CELLULAR PROTEIN ANTIGENS IN SERUM

Mike Cawthorne:



3. (WO 01/16603) METHODS AND COMPOSITIONS RELATING TO BODY WEIGHT AND EATING DISORDERS
4. (WO 00/73330) METHOD AND COMPOSITIONS RELATING TO INSULIN RESISTANCE DISORDERS
[Repub: 22.02.2001]
5. (WO 01/01130) METHODS AND COMPOSITIONS RELATING TO PANCREATIC ISLET AND ß-CELL DYSFUNCTION
6. (WO 00/73330) METHOD AND COMPOSITIONS RELATING TO INSULIN RESISTANCE DISORDERS

Cameron:

1. (WO 00/31290) METHODS AND COMPOSITIONS FOR PAIN MANAGEMENT
[Repub: 29.03.2001]
2. (WO 00/31290) METHODS AND COMPOSITIONS FOR PAIN MANAGEMENT

Dunn and Rose:

1. (WO 2002/010755) ORGAN TRANSPLANT REJECTION AND ASSOCIATED CONDITIONS
[Repub: 09.09.2005]
2. (WO 02/010755) ORGAN TRANSPLANT REJECTION AND ASSOCIATED CONDITIONS
[Repub: 09.10.2003]
3. (WO 01/40302) ORGAN TRANSPLANT REJECTION AND ASSOCIATED CONDITIONS
[Repub: 21.03.2002]
4. (WO 02/10755) ORGAN TRANSPLANT REJECTION AND ASSOCIATED CONDITIONS
5. (WO 01/40302) ORGAN TRANSPLANT REJECTION AND ASSOCIATED CONDITIONS

Hochstrasser:



5. (WO 2005/029088) DIAGNOSTIC METHOD FOR BRAIN DAMAGE-RELATED DISORDERS
[Repub: 15.09.2005]
6. (WO 2004/044574) DEVICE FOR SEPARATING AND METHOD FOR SEPARATING A BIOMOLECULAR SUBSTANCE SAMPLE
[Repub: 11.08.2005]
7. (WO 2005/017523) METHOD FOR DISCRIMINATING BETWEEN ISCHEMIC AND HAEMORRHAGIC STROKE
[Repub: 12.05.2005]
8. (WO 2005/029088) DIAGNOSTIC METHOD FOR BRAIN DAMAGE-RELATED DISORDERS
9. (WO 2005/017523) DIAGNOSTIC METHOD FOR STROKE
10. (WO 2004/040316) DIAGNOSTIC METHOD FOR TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES (PRION DISEASES)
[Repub: 29.12.2004]
11. (WO 2004/019043) POLYPEPTIDE BIOMARKERS FOR DIAGNOSING ALZHEIMER'S DISEASE
[Repub: 24.06.2004]
12. (WO 2004/044574) DEVICE FOR SEPARATING AND METHOD FOR SEPARATING A BIOMOLECULAR SUBSTANCE SAMPLE
13. (WO 2004/040316) DIAGNOSTIC METHOD FOR TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES
14. (WO 2003/069346) DIAGNOSTIC METHOD FOR STROKE
[Repub: 11.03.2004]
15. (WO 2004/019043) BIOMARKERS FOR DIAGNOSING ALZHEIMER'S DISEASE
16. (WO 2003/023406) DIAGNOSTIC METHOD FOR TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES
[Repub: 26.02.2004]
17. (WO 2003/087837) METHODS AND SYSTEMS FOR DONOR SAMPLE MANAGEMENT AND POOLING FOR USE IN PROTEOMIC STUDIES
[Repub: 05.02.2004]
18. (WO 03/023406) DIAGNOSTIC METHOD FOR TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES
[Repub: 27.11.2003]
19. (WO 03/087837) METHODS AND SYSTEMS FOR DONOR SAMPLE MANAGEMENT AND POOLING FOR USE IN PROTEOMIC STUDIES
20. (WO 03/069346) DIAGNOSTIC METHOD FOR STROKE
24. (WO 03/023406) DIAGNOSTIC METHOD FOR TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES
25. (WO 01/67108) DIAGNOSTIC ASSAY FOR TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES
[Repub: 21.03.2002]

Brax/Xzillion

1. (WO 2005/012914) METHOD FOR CHARACTERISING POLYPEPTIDES BY MALDI-TOF MAS SPECTROMETRY
[Repub: 30.06.2005]
2. (WO 2005/012914) CHARACTERISING POLYPEPTIDES
3. (WO 2004/086050) LABELLING AGENTS FOR MASS SPECTROMETRY COMPRISING TERTIARY AMINES
[Repub: 29.12.2004]
4. (WO 2004/102180) MASS SPECTROMETRY
5. (WO 2004/086050) MASS LABELS
6. (WO 2003/104813) MODIFICATION OF POLYPEPTIDES FOR CHARACTERISATION PURPOSES
[Repub: 03.06.2004]
7. (WO 03/104813) CHARACTERISING POLYPEPTIDES
8. (WO 03/021274) METHOD FOR SEPARATING MACROMOLECULES HAVING BEEN CHEMICALLY MODIFIED IN A REVERSIBLE MANNER
[Repub: 27.11.2003]
9. (WO 03/087839) METHOD FOR CHARACTERISING ANALYTES
10. (WO 03/025576) MASS LABELS
[Repub: 31.07.2003]
11. (WO 02/099124) CHARACTERISING POLYPEPTIDES
[Repub: 17.07.2003]
12. (WO 02/099436) CHARACTERISING POLYPEPTIDES
[Repub: 22.05.2003]
13. (WO 03/025576) MASS LABELS
14. (WO 03/021274) METHOD FOR SEPARATING MACROMOLECULES HAVING BEEN CHEMICALLY MODIFIED IN A REVERSIBLE MANNER
15. (WO 02/099404) METHOD FOR ELECTROPHORETIC SAMPLE SEPARATION
[Repub: 27.02.2003]
16. (WO 02/099436) CHARACTERISING POLYPEPTIDES
17. (WO 02/099435) METHOD FOR CHARACTERIZING POLYPEPTIDES
18. (WO 02/099404) METHOD FOR ELECTROPHORETIC SAMPLE SEPARATION
19. (WO 02/099124) CHARACTERISING POLYPEPTIDES
20. (WO 02/16424) DNA BINDING PEPTIDE DOMAINS AND A METHOD FOR PROVIDING DOMAINS OF THIS TYPE
[Repub: 16.05.2002]
21. (WO 01/68664) MASS LABELS
[Repub: 21.03.2002]
22. (WO 02/16574) METHOD FOR IDENTIFYING PEPTIDES THAT CAN BE SPECIFICALLY CLEAVED AND THE USE OF PEPTIDE SEQUENCES OF THIS TYPE
23. (WO 02/16424) DNA BINDING PEPTIDE DOMAINS AND A METHOD FOR PROVIDING DOMAINS OF THIS TYPE
24. (WO 02/04656) BIO-PROBES AND USE THEREOF

1. (WO 01/68664) MASS LABELS
2. (WO 00/20870) CHARACTERISING POLYPEPTIDES THROUGH CLEAVAGE AND MASS SPECTROMETRY
3. (WO 00/02895) ARYLSULFONE LINKERS FOR MASS SPECTROMETRIC ANALYSIS
4. (WO 00/02894) SILICON-CONTAINING LINKERS FOR NUCLEIC ACID MASS MARKERS
5. (WO 00/02893) METAL ION-BINDING MASS MARKERS FOR NUCLEIC ACIDS
6. (WO 99/45145) SCREENING FOR FUNCTIONAL ANTISENSE AGENTS
7. (WO 99/45144) SCREENING FOR FUNCTIONAL ANTISENSE AGENTS
8. (WO 99/32501) COMPOUNDS FOR MASS SPECTROMETRY COMPRISING NUCLEIC ACID BASES AND ARYL ETHER MASS MARKERS
9. (WO 99/27086) CHIMERIC ANTISENSE OLIGONUCLEOTIDES AGAINST TNF-ALPHA AND THEIR USES
10. (WO 99/14362) CHARACTERISING NUCLEIC ACID BY MASS SPECTROMETRY
11. (WO 99/13103) CATALYTICALLY GENERATED MASS LABELS
12. (WO 98/48047) CHARACTERISING DNA
[Repub: 28.01.1999]
13. (WO 99/02728) CHARACTERISING NUCLEIC ACIDS
14. (WO 99/02727) CATEGORISING NUCLEIC ACID
15. (WO 99/02726) CHARACTERISING NUCLEIC ACID
16. (WO 99/02725) CATEGORISING NUCLEIC ACID
17. (WO 98/48047) CHARACTERISING DNA
18. (WO 98/32876) CHARACTERISING POLYPEPTIDES
19. (WO 98/31831) NUCLEIC ACID SEQUENCING
20. (WO 98/31830) MASS LABEL LINKED HYBRIDISATION PROBES
21. (WO 98/15652) NUCLEIC ACID SEQUENCING BY ADAPTATOR LIGATION
22. (WO 98/15651) IDENTIFYING ANTISENSE OLIGONUCLEOTIDE BINDING
23. (WO 98/10095) CHARACTERISING DNA
24. (WO 97/10332) CHIMAERIC OLIGONUCLEOTIDES AND USES THEREOF IN THE IDENTIFICATION OF ANTISENSEBINDING SITES


Intronn/wipo-pct


1. (WO 2005/070023) EXPRESSION OF APOA-1 AND VARIANTS THEREOF USING SPLICEOSOME MEDIATED RNA TRANS-SPLICING
[Repub: 12.01.2006]
2. (WO 2005/070948) CORRECTION OF ALPHA-1-ANTITRYPSIN GENETIC DEFECTS USING SPLICEOSOME MEDIATED RNA TRANS SPLICING
3. (WO 2005/070023) EXPRESSION OF APOA-1 AND VARIANTS THEREOF USING SPLICEOSOME MEDIATED RNA TRANS-SPLICING
4. (WO 2005/023990) TRANS-SPLICING MEDIATED PHOTODYNAMIC THERAPY
[Repub: 14.07.2005]
5. (WO 2004/038380) SCREENING METHODS FOR IDENTIFICATION OF EFFICIENT PRE-TRANS-SPLICING MOLECULES
[Repub: 21.04.2005]
6. (WO 2003/069311) METHODS AND COMPOSITIONS FOR USE IN SPLICEOSOME MEDIATED RNA TRANS-SPLICING
[Repub: 21.04.2005]
7. (WO 2005/023990) TRANS-SPLICING MEDIATED PHOTODYNAMIC THERAPY
8. (WO 2003/104412) SPLICEOSOME MEDIATED RNA TRANS-SPLICING AND CORRECTION OF FACTOR VIII GENETIC DEFECTS
[Repub: 17.02.2005]
9. (WO 2004/050680) USE OF SPLICEOSOME MEDIATED RNA TRANS-SPLICING TO CONFER CELL SELECTIVE REPLICATION TO ADENOVIRUSES
[Repub: 12.08.2004]
10. (WO 2003/104416) SPLICEOSOME MEDIATED RNA TRANS-SPLICING IN STEM CELLS
[Repub: 01.07.2004]
11. (WO 2004/050680) USE OF SPLICEOSOME MEDIATED RNA TRANS-SPLICING TO CONFER CELL SELECTIVE REPLICATION TO ADENOVIRUSES
12. (WO 2003/093414) TRANSGENIC ANIMAL MODEL FOR SPLICEOSOME-MEDIATED RNA TRANS-SPLICING
[Repub: 06.05.2004]
13. (WO 2004/038380) SCREENING METHODS FOR IDENTIFICATION OF EFFICIENT PRE-TRANS-SPLICING MOLECULES
14. (WO 2004/006678) SPLICEOSOME MEDIATED RNA TRANS-SPLICING FOR CORRECTION OF SKIN DISORDERS
15. (WO 03/104416) SPLICEOSOME MEDIATED RNA TRANS-SPLICING IN STEM CELLS
16. (WO 03/104412) SPLICEOSOME MEDIATED RNA TRANS-SPLICING AND CORRECTION OF FACTOR VIII GENETIC DEFECTS USING SPLICEOSOME MEDIATED RNA TRANS SPLING
17. (WO 03/072739) TRANS-SPLICING MEDIATED IMAGING OF GENE EXPRESSION
[Repub: 13.11.2003]
18. (WO 03/093414) TRANSGENIC ANIMAL MODEL FOR SPLICEOSOME-MEDIATED RNA TRANS-SPLICING
19. (WO 03/072739) TRANS-SPLICING MEDIATED IMAGING OF GENE EXPRESSION
20. (WO 03/069311) METHODS AND COMPOSITIONS FOR USE IN SPLICEOSOME MEDIATED RNA TRANS-SPLICING
21. (WO 02/053581) SPLICEOSOME MEDIATED RNA TRANS-SPLICING
[Repub: 26.09.2002]
22. (WO 02/053581) METHODS AND COMPOSITIONS FOR USE IN SPLICEOSOME MEDIATED RNA TRANS-SPLICING
23. (WO 01/49745) METHODS AND COMPOSITIONS FOR DETERMINING THE PURITY OF CHEMICALLY SYNTHESIZED NUCLEIC ACIDS
[Repub: 20.09.2001]
24. (WO 01/49745) METHODS AND COMPOSITIONS FOR DETERMINING THE PURITY OF CHEMICALLY SYNTHESIZED NUCLEIC ACIDS
25. (WO 00/09734) METHODS AND COMPOSITIONS FOR USE IN SPLICEOSOME MEDIATED RNA TRANS-SPLICING
[Repub: 13.07.2000]
26. (WO 00/09734) METHODS AND COMPOSITIONS FOR USE IN SPLICEOSOME MEDIATED RNA TRANS-SPLICING
[Repub: 18.05.2000]
27. (WO 00/09734) METHODS AND COMPOSITIONS FOR USE IN SPLICEOSOME MEDIATED RNA TRANS-SPLICING
28. (WO 98/14275) SAMPLE COLLECTION DEVICES AND METHODS USING MARKERS AND THE USE OF SUCH MARKERSAS CONTROLS IN SAMPLE VALIDATION, LABORATORY EVALUATION AND/OR ACCREDITATION
29. (WO 97/22250) THERAPEUTIC MOLECULES GENERATED BY TRANS-SPLICING




Patents granted US Intronn:

PAT. NO. Title
1 6,673,621 Sample collection devices and methods using markers and the use of such markers as controls in sample validation, laboratory evaluation and/or accreditation
2 6,280,978 Methods and compositions for use in spliceosome mediated RNA trans-splicing
3 6,083,702 Methods and compositions for use in spliceosome mediated RNA trans-splicing

Patents applied for US Intronn:

PUB. APP. NO. Title
1 20040248141 Spliceosome mediated RNA trans-splicing for correction of skin disorders
2 20040018622 Spliceosome mediated RNA trans-splicing for correction of skin disorders

US Patents applied Garcia Blanco:


3 20040214263 Spliceosome mediated RNA trans-splicing

9 20030153054 Methods and compositions for use in spliceosome mediated RNA trans-splicing
10 20030148937 Methods and compositions for use in spliceosome mediated RNA trans-splicing
11 20030077754 Methods and compositions for use in spliceosome mediated RNA trans-splicing
12 20030027250 Methods and compositions for use in spliceosome mediated RNA trans-splicing
13 20020193580 Methods and compositions for use in spliceosome mediated RNA trans-splicing
15 20020115207 Methods and compositions for use in spliceosome mediated RNA trans-splicing 17 20020009755 ALTERNATIVE SPLICING OF FIBROBLAST GROWTH FACTOR RECEPTOR 2 MRNA IN PROSTATE CANCER


Wipo Pct Garcia AND Blanco


1. (WO 2005/070023) EXPRESSION OF APOA-1 AND VARIANTS THEREOF USING SPLICEOSOME MEDIATED RNA TRANS-SPLICING
[Repub: 12.01.2006]
4. (WO 2005/070948) CORRECTION OF ALPHA-1-ANTITRYPSIN GENETIC DEFECTS USING SPLICEOSOME MEDIATED RNA TRANS SPLICING
5. (WO 2005/070023) EXPRESSION OF APOA-1 AND VARIANTS THEREOF USING SPLICEOSOME MEDIATED RNA TRANS-SPLICING
8. (WO 2004/038380) SCREENING METHODS FOR IDENTIFICATION OF EFFICIENT PRE-TRANS-SPLICING MOLECULES
[Repub: 21.04.2005]
9. (WO 2003/069311) METHODS AND COMPOSITIONS FOR USE IN SPLICEOSOME MEDIATED RNA TRANS-SPLICING
[Repub: 21.04.2005]
11. (WO 2003/104412) SPLICEOSOME MEDIATED RNA TRANS-SPLICING AND CORRECTION OF FACTOR VIII GENETIC DEFECTS
[Repub: 17.02.2005]
13. (WO 2003/093414) TRANSGENIC ANIMAL MODEL FOR SPLICEOSOME-MEDIATED RNA TRANS-SPLICING
[Repub: 06.05.2004]
14. (WO 2004/038380) SCREENING METHODS FOR IDENTIFICATION OF EFFICIENT PRE-TRANS-SPLICING MOLECULES
16. (WO 03/104412) SPLICEOSOME MEDIATED RNA TRANS-SPLICING AND CORRECTION OF FACTOR VIII GENETIC DEFECTS USING SPLICEOSOME MEDIATED RNA TRANS SPLING
18. (WO 03/093414) TRANSGENIC ANIMAL MODEL FOR SPLICEOSOME-MEDIATED RNA TRANS-SPLICING
19. (WO 03/069311) METHODS AND COMPOSITIONS FOR USE IN SPLICEOSOME MEDIATED RNA TRANS-SPLICING
20. (WO 02/053581) SPLICEOSOME MEDIATED RNA TRANS-SPLICING
[Repub: 26.09.2002]
21. (WO 02/053581) METHODS AND COMPOSITIONS FOR USE IN SPLICEOSOME MEDIATED RNA TRANS-SPLICING


Wipo Pct Agris AND Paul:


1. (WO 01/49745) METHODS AND COMPOSITIONS FOR DETERMINING THE PURITY OF CHEMICALLY SYNTHESIZED NUCLEIC ACIDS
[Repub: 20.09.2001]
2. (WO 01/49745) METHODS AND COMPOSITIONS FOR DETERMINING THE PURITY OF CHEMICALLY SYNTHESIZED NUCLEIC ACIDS

Veri-q Wipo Pct:


1. (WO 2003/003014) METHODS AND COMPOSITIONS FOR DETERMINING THE PURITY OF AND PURIFYING CHEMICALLY SYNTHESIZED NUCLEIC ACIDS
[Repub: 13.05.2004]
2. (WO 03/003014) METHODS AND COMPOSITIONS FOR DETERMINING THE PURITY OF AND PURIFYING CHEMICALLY SYNTHESIZED NUCLEIC ACIDS
32. (WO 01/49745) METHODS AND COMPOSITIONS FOR DETERMINING THE PURITY OF CHEMICALLY SYNTHESIZED NUCLEIC ACIDS

Search "Proteome" and "Cobham" Wipo Pct:

1. (WO 2005/123048) SCREENING METHODS
2. (WO 2005/012914) METHOD FOR CHARACTERISING POLYPEPTIDES BY MALDI-TOF MAS SPECTROMETRY
[Repub: 30.06.2005]
3. (WO 2005/001114) SCREENING METHODS
[Repub: 31.03.2005]
4. (WO 2005/012914) CHARACTERISING POLYPEPTIDES
5. (WO 2005/001114) SCREENING METHODS
6. (WO 2004/086050) LABELLING AGENTS FOR MASS SPECTROMETRY COMPRISING TERTIARY AMINES
[Repub: 29.12.2004]
7. (WO 2004/040316) DIAGNOSTIC METHOD FOR TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES (PRION DISEASES)
[Repub: 29.12.2004]
8. (WO 2004/102180) MASS SPECTROMETRY
9. (WO 2004/086050) MASS LABELS
10. (WO 2003/104813) MODIFICATION OF POLYPEPTIDES FOR CHARACTERISATION PURPOSES
[Repub: 03.06.2004]
11. (WO 2003/003014) METHODS AND COMPOSITIONS FOR DETERMINING THE PURITY OF AND PURIFYING CHEMICALLY SYNTHESIZED NUCLEIC ACIDS
[Repub: 13.05.2004]
12. (WO 2004/040316) DIAGNOSTIC METHOD FOR TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES
13. (WO 2003/023406) DIAGNOSTIC METHOD FOR TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES
[Repub: 26.02.2004]
14. (WO 03/104813) CHARACTERISING POLYPEPTIDES
15. (WO 03/023406) DIAGNOSTIC METHOD FOR TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES
[Repub: 27.11.2003]
16. (WO 01/16603) ANALYSIS AND TREATMENT OF BODY WEIGHT AND EATING DISORDERS
[Repub: 20.09.2001]
17. (WO 01/16603) METHODS AND COMPOSITIONS RELATING TO BODY WEIGHT AND EATING DISORDERS
18. (WO 00/73330) METHOD AND COMPOSITIONS RELATING TO INSULIN RESISTANCE DISORDERS
[Repub: 22.02.2001]
19. (WO 01/01130) METHODS AND COMPOSITIONS RELATING TO PANCREATIC ISLET AND ß-CELL DYSFUNCTION
20. (WO 00/73330) METHOD AND COMPOSITIONS RELATING TO INSULIN RESISTANCE DISORDERS
21. (WO 99/06388) PHARMACEUTICAL COMPOUNDS ISOLATED FROM ARISTOLOCHIA TALISCANA
[Repub: 15.06.2000]
22. (WO 98/23962) DIAGNOSIS OF PRION DISEASES
[Repub: 17.02.2000]
23. (WO 98/43091) DIAGNOSIS OF EPITHELIAL CELL ABNORMALITIES
24. (WO 98/42736) DIAGNOSIS OF COLORECTAL CANCER AND PROTEINS AND ANTIBODIES FOR USE THEREIN

Electrophoretics Wipo/Pct:

1. (WO 2004/102180) MASS SPECTROMETRY
[Repub: 19.01.2006]
2. (WO 99/06388) PHARMACEUTICAL COMPOUNDS ISOLATED FROM ARISTOLOCHIA TALISCANA
[Repub: 22.04.1999]
3. (WO 99/06388) PHARMACEUTICAL COMPOUNDS ISOLATED FROM ARISTOLOCHIA TALISCANA
4. (WO 98/35985) PROTEIN MARKERS FOR LUNG CANCER AND USE THEREOF
[Repub: 12.11.1998]
5. (WO 98/35985) PROTEIN MARKERS FOR LUNG CANCER AND USE THEREOF
6. (WO 98/23962) DIAGNOSIS OF PRION DISEASES
7. (WO 97/45445) PROTEIN MARKERS FOR ESOPHAGEAL CANCER
8. (WO 97/04315) PROTEIN P5, A SERUM MARKER FOR BRAIN DAMAGE

Christopher Pearce Wipo-Pct:

10. (WO 2005/012914) CHARACTERISING POLYPEPTIDES
32. (WO 01/49745) METHODS AND COMPOSITIONS FOR DETERMINING THE PURITY OF CHEMICALLY SYNTHESIZED NUCLEIC ACIDS
40. (WO 98/23962) DIAGNOSIS OF PRION DISEASES

[1xtrader] 11/3/2021 13:38

My next question has proteome Sciences got the patents to this test

[monte1] 11/3/2021 13:28

BUY - Joy Milne (68)


dyor

[tom barnaby] 11/3/2021 13:25

Retired nurse Joy Milne, 68, from Perth, noticed the "musky" smell on her husband, Les, years before his Parkinson's diagnosis.
She has been helping scientists at the University of Manchester explore the link.
And a blinded test of her odour-detecting skills found she was 100% accurate.

[1xtrader] 11/3/2021 13:21

The research team moved on to using a mass-spectrometry machine to detect the compounds.And they now have data from 500 people, showing the skin test can correctly distinguish those with Parkinson's more than eight out of every 10 times.Investigator Prof Perdita Barran said: "We believe that our results are an extremely encouraging step towards tests that could be used to help diagnose and monitor Parkinson's."Not only is the test quick, simple and painless but it should also be extremely cost-effective because it uses existing technology that is already widely available."We are now looking to take our findings forwards to refine the test to improve accuracy even further and to take steps towards making this a test that can be used in the NHS and to develop more precise diagnostics and better treatment for this debilitating condition."Disease progressionCurrently, there is no cure and no definitive test for Parkinson's.And diagnosis can take years.The researchers are seeking funding to further develop their test, which they believe could also help track disease progression and measure whether treatments are having an impact, at the molecular level.Their latest work, published in the journal Nature Communications, suggests progression of the disease comes with changes in the regulation of lipids in cells.'Enjoy life'Daxa Kalayci, 56, of Leicester, was misdiagnosed several times over four years before finally finding out she had Parkinson's in 2019."I was misdiagnosed with anxiety, stress-related tremors and told that my problems stemmed from going through the menopause," she said."Despite my diagnosis eventually being confirmed... a quick and simple diagnostic test for Parkinson's would have given me the chance to start my treatment earlier and enjoy life a lot more."But instead, I lost so many years not being able to pursue a career as a paramedic or go back to nursing."This test could be a game-changer for people living with Parkinson's and searching for answers, like I was."A simple skin-swab test could be used to help diagnose the degenerative brain condition Parkinson's disease, UK scientists say.Studies with volunteers show it can quickly detect tell-tale compounds in sebum - the oily substance that protects the skin.People with Parkinson's can have higher than usual concentrations of these.Researchers discovered this after a woman amazed doctors with her ability to detect Parkinson's through smell.Retired nurse Joy Milne, 68, from Perth, noticed the "musky" smell on her husband, Les, years before his Parkinson's diagnosis.She has been helping scientists at the University of Manchester explore the link.And a blinded test of her odour-detecting skills found she was 100% accurate.

[tom barnaby] 11/3/2021 13:14

The formatting of this free bb, eh?

Woeful!

[tom barnaby] 11/3/2021 13:13

You can but dream, monte1.

16 0 Tue 23:19 pools2 Automation Advances Could Streamline Large-Scale Tandem Mass Tagging Experiments read more...
13 0 yesterday 11:54 colinhy Re GenomeWeb article published yesterday about "Automation Advances Could Streamline Large-Scale Tandem Mass Tagging" The above article was based on a research paper published by Calico and PreOmics. Further info in my post #58302 January 26, 2021 Calico Life Sciences LLC and Thermo Fisher Scientific have published a paper for the automation of 16-Plex Plasma Proteomics with Real-Time... read more...
10 0 4 hours ago colinhy Investor Interest in Proteomics Rising on New, Improving Technologies Mar 10, 2021 | Adam Bonislawski Premium NEW YORK – Investor interest in proteomics appears to be on the rise as over the last year several private firms have announced large fundraising rounds and a number of other companies have made plans to go public. At the same time, some more established life science companies... read more...
9 0 Tue 17:20 1xtrader anyone listen in very interesting and fantastic appraisal of proteome sciences services read more...
8 0 yesterday 09:57 wasjobber Why don't all you fools, simply click on the Genomeweb free trial button? Then you get free access to read the most bullish publication for TMT that I've ever seen! read more...
7 0 05 Mar 2021 1xtrader Well lots to factor in,forward earnings and take into consideration of the Edison 2012 report is one way but 12 million at it’s current value is a steal for the likes of multi billion pound company, there are many pharmaceutical companies valued ten times proteome sciences and not making a penny, and don’t have many projects but my gut feeling is minimum £60 million up to £200 million read more...
7 0 04 Mar 2021 small crow Oooh - what do you call a flock of filtereds" A gaggle - like geese? Certainly not a charm, like goldfinches? read more...
6 0 Mon 12:51 small crow It's a higher low. read more...
5 0 Tue 17:03 wrighty41 Only a matter of time before we see the back of 5p. Time being of the shorter variety! W41 read more...
4 0 4 hours ago 1xtrader Hope one of these big American companies will see Proteome Sciences and make an offer read more...